Astrocytoma [clinicaltrials_resource:41a1c30b6b332fc273a6dcc9a7d95db9]
Detecting Malignant Brain Tumor Cells in the Bloodstream During Surgery to Remove the Tumor [clinicaltrials:NCT00001148]Natural History of Patients With Brain and Spinal Cord Tumors [clinicaltrials:NCT00009035]Safety and Effectiveness Study of G207, a Tumor-Killing Virus, in Patients With Recurrent Brain Cancer [clinicaltrials:NCT00028158]Genetic Analysis of Brain Tumors [clinicaltrials:NCT00031538]A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas [clinicaltrials:NCT00080054]clinicaltrials:NCT00154375Prolonged Daily Temozolomide for Low-Grade Glioma [clinicaltrials:NCT00165360]Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors [clinicaltrials:NCT00179803]Efficacy and Safety of Temodal vs Semustine in Subjects With Recurrent Glioblastoma or Anaplastic Astrocytoma (Study P03644) [clinicaltrials:NCT00335075]clinicaltrials:NCT00360828clinicaltrials:NCT00389090The Effects of Continuous 28-day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-day (5/28) Treatment (P04601AM1)(COMPLETED) [clinicaltrials:NCT00392171]clinicaltrials:NCT00575887Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma [clinicaltrials:NCT00591058]clinicaltrials:NCT00624728A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma [clinicaltrials:NCT00683761]Temozolomide All-Case-Registered Surveillance (Designated Drug Use Investigation)(Study P05062) [clinicaltrials:NCT00705198]Temodal (Temozolomide) Post Marketing Surveillance Protocol (Study P05557AM2) [clinicaltrials:NCT00723827]SCH 52365 Phase II Clinical Study: A Study on the Efficacy and Safety of Monotherapy With SCH 52365 in Patients With First Relapsed Anaplastic Astrocytoma (Study P03745) [clinicaltrials:NCT00783393]clinicaltrials:NCT00795457Phase II Trial of RAD001 in Patients With Recurrent Low Grade Glioma [clinicaltrials:NCT00823459]clinicaltrials:NCT00874861A Study to Evaluate the Efficacy of Bevacizumab Plus Irinotecan in Recurrent Gliomas [clinicaltrials:NCT00921167]A Phase I Study of ABT-888, an Oral Inhibitor of Poly(ADP-ribose) Polymerase and Temozolomide in Children With Recurrent/Refractory CNS Tumors [clinicaltrials:NCT00994071]clinicaltrials:NCT01044966FET-PET for Diagnosis and Monitoring in Patients With Low Grade Glioma [clinicaltrials:NCT01089244]A Pilot Study Evaluating 18F-L-Thymidine (FLT) PET Imaging in Children With Gliomas [clinicaltrials:NCT01117155]A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB [clinicaltrials:NCT01125800]Proton Radiotherapy for Pediatric Brain Tumors Requiring Partial Brain Irradiation [clinicaltrials:NCT01288235]clinicaltrials:NCT01331135A Study of Aminolevulinic Acid Used to Enhance Visualization and Surgical Removal of Brain Tumors [clinicaltrials:NCT01351519]Phase I Study of Orally Administered Aminolevulinic Acid for Resection of Malignant Astrocytomas [clinicaltrials:NCT01502605]Combined O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) Positron Emission Tomography (PET) and Simultaneous Magnetic Resonance Imaging (MRI) Follow-up in Re-irradiated Recurrent Glioblastoma Patients [clinicaltrials:NCT01579253]Efficacy of Post-radiation Adjuvant Temozolomide Chemotherapy in Residue Low-grade Glioma [clinicaltrials:NCT01649830]Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas [clinicaltrials:NCT01849952]clinicaltrials:NCT01906385Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma [clinicaltrials:NCT02010606]clinicaltrials:NCT02209428clinicaltrials:NCT02372409Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Recurrent or Refractory Brain Tumors [clinicaltrials:NCT02444546]
condition [clinicaltrials_vocabulary:condition]
Detecting Malignant Brain Tumor Cells in the Bloodstream During Surgery to Remove the Tumor [clinicaltrials:NCT00001148]clinicaltrials:NCT00002463Combination Chemotherapy for Patients With Brain Cancer [clinicaltrials:NCT00002814]Antineoplaston Therapy in Treating Children With Low-Grade Astrocytoma [clinicaltrials:NCT00003468]Antineoplaston Therapy in Treating Patients With Anaplastic Astrocytoma [clinicaltrials:NCT00003470]Antineoplaston Therapy in Treating Patients With Low-Grade Astrocytoma [clinicaltrials:NCT00003471]Antineoplaston Therapy in Treating Patients With Residual or Recurrent Anaplastic Astrocytoma [clinicaltrials:NCT00003537]clinicaltrials:NCT00003621Leflunomide in Treating Patients With Anaplastic Astrocytoma in First Relapse [clinicaltrials:NCT00003775]IL-4(38-37)-PE38KDEL Immunotoxin in Treating Patients With Recurrent Malignant Astrocytoma [clinicaltrials:NCT00003842]Radiolabeled Monoclonal Antibody in Treating Patients With Glioblastoma Multiforme or Anaplastic Astrocytoma [clinicaltrials:NCT00004017]Irinotecan in Treating Children With Refractory Solid Tumors [clinicaltrials:NCT00004078]clinicaltrials:NCT00004259Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms [clinicaltrials:NCT00004688]SU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation Therapy [clinicaltrials:NCT00004868]Magnetic Resonance Imaging in Treating Children With Progressive Low-Grade Astrocytoma [clinicaltrials:NCT00005084]Bortezomib in Treating Patients With Recurrent Glioma [clinicaltrials:NCT00006773]Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma [clinicaltrials:NCT00008008]Natural History of Patients With Brain and Spinal Cord Tumors [clinicaltrials:NCT00009035]Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas [clinicaltrials:NCT00012181]clinicaltrials:NCT00017147Stereotactic Radiosurgery in Treating Patients With Brain Tumors [clinicaltrials:NCT00019578]Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients [clinicaltrials:NCT00024557]Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma [clinicaltrials:NCT00024570]Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction [clinicaltrials:NCT00030498]Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas [clinicaltrials:NCT00031083]Genetic Analysis of Brain Tumors [clinicaltrials:NCT00031538]Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute s (NCI) Clinical Research Protocols [clinicaltrials:NCT00035373]Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma [clinicaltrials:NCT00041587]clinicaltrials:NCT00042991Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma [clinicaltrials:NCT00045110]A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas [clinicaltrials:NCT00045708]clinicaltrials:NCT00045968Tipifarnib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma [clinicaltrials:NCT00049387]Immunotoxin Therapy in Treating Children With Progressive or Recurrent Glioblastoma Multiforme or Anaplastic Astrocytoma [clinicaltrials:NCT00052624]Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors [clinicaltrials:NCT00052780]FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia [clinicaltrials:NCT00053963]Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas [clinicaltrials:NCT00062504]Cilengitide in Treating Children With Refractory Primary Brain Tumors [clinicaltrials:NCT00063973]Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma [clinicaltrials:NCT00064779]
condition browse [clinicaltrials_vocabulary:condition-browse]
Detecting Malignant Brain Tumor Cells in the Bloodstream During Surgery to Remove the Tumor [clinicaltrials:NCT00001148]clinicaltrials:NCT00002463Combination Chemotherapy for Patients With Brain Cancer [clinicaltrials:NCT00002814]Antineoplaston Therapy in Treating Children With Low-Grade Astrocytoma [clinicaltrials:NCT00003468]Antineoplaston Therapy in Treating Patients With Anaplastic Astrocytoma [clinicaltrials:NCT00003470]Antineoplaston Therapy in Treating Patients With Low-Grade Astrocytoma [clinicaltrials:NCT00003471]Antineoplaston Therapy in Treating Patients With Residual or Recurrent Anaplastic Astrocytoma [clinicaltrials:NCT00003537]clinicaltrials:NCT00003621Leflunomide in Treating Patients With Anaplastic Astrocytoma in First Relapse [clinicaltrials:NCT00003775]IL-4(38-37)-PE38KDEL Immunotoxin in Treating Patients With Recurrent Malignant Astrocytoma [clinicaltrials:NCT00003842]Radiolabeled Monoclonal Antibody in Treating Patients With Glioblastoma Multiforme or Anaplastic Astrocytoma [clinicaltrials:NCT00004017]Irinotecan in Treating Children With Refractory Solid Tumors [clinicaltrials:NCT00004078]clinicaltrials:NCT00004259Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms [clinicaltrials:NCT00004688]SU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation Therapy [clinicaltrials:NCT00004868]Magnetic Resonance Imaging in Treating Children With Progressive Low-Grade Astrocytoma [clinicaltrials:NCT00005084]Bortezomib in Treating Patients With Recurrent Glioma [clinicaltrials:NCT00006773]Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma [clinicaltrials:NCT00008008]Natural History of Patients With Brain and Spinal Cord Tumors [clinicaltrials:NCT00009035]Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas [clinicaltrials:NCT00012181]clinicaltrials:NCT00017147Stereotactic Radiosurgery in Treating Patients With Brain Tumors [clinicaltrials:NCT00019578]Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients [clinicaltrials:NCT00024557]Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma [clinicaltrials:NCT00024570]Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction [clinicaltrials:NCT00030498]Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas [clinicaltrials:NCT00031083]Genetic Analysis of Brain Tumors [clinicaltrials:NCT00031538]Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute s (NCI) Clinical Research Protocols [clinicaltrials:NCT00035373]Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma [clinicaltrials:NCT00041587]clinicaltrials:NCT00042991Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma [clinicaltrials:NCT00045110]A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas [clinicaltrials:NCT00045708]clinicaltrials:NCT00045968Tipifarnib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma [clinicaltrials:NCT00049387]Immunotoxin Therapy in Treating Children With Progressive or Recurrent Glioblastoma Multiforme or Anaplastic Astrocytoma [clinicaltrials:NCT00052624]Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors [clinicaltrials:NCT00052780]FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia [clinicaltrials:NCT00053963]Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas [clinicaltrials:NCT00062504]Cilengitide in Treating Children With Refractory Primary Brain Tumors [clinicaltrials:NCT00063973]Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma [clinicaltrials:NCT00064779]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Astrocytoma [clinicaltrials_resource:41a1c30b6b332fc273a6dcc9a7d95db9]
Bio2RDF identifier
41a1c30b6b332fc273a6dcc9a7d95db9
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:41a1c30b6b332fc273a6dcc9a7d95db9
identifier
clinicaltrials_resource:41a1c30b6b332fc273a6dcc9a7d95db9
title
Astrocytoma
@en
type
label
Astrocytoma [clinicaltrials_resource:41a1c30b6b332fc273a6dcc9a7d95db9]
@en
Astrocytoma